Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	119.43K
Revenue (ttm)	1.56M
Net Income (ttm)	-879.00K
Shares Out	66.35M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	530
Average Volume	1,986
Open	0.0065
Previous Close	0.0065
Day's Range	0.0018 - 0.0066
52-Week Range	0.0002 - 0.7530
Beta	50.57
RSI	39.57
Earnings Date	Feb 28, 2025

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR

Financial Performance

In 2021, Acura Pharmaceuticals's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$879,000, -27.24% less than in 2020.